<?xml version="1.0" encoding="UTF-8"?>
<p id="par0340">Tuberculosis vaccine (VPM1002), on the other hand, is a new vaccine based on the old BCG vaccine. The idea is that in many studies conducted on mice, the vaccinated mice had lower influenza, lower serum viral load, and less lung damage. It is claimed that the BCG vaccine may activate the immune system against viruses and possibly decrease COVID-19 mortality rates [
 <xref rid="bib0500" ref-type="bibr">100</xref>].
</p>
